Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 'Bumps down under:' hemorrhoids, skin tags and all things perianal.1 passage
• A brave new world: the gastrointestinal lab during and after a pandemic.1 passage
• A gut (microbiome) feeling about the brain.1 passage
• A rational approach to the patient with hematochezia.1 passage
• Acute on chronic liver failure: definitions, treatments and outcomes.1 passage
• Acute pancreatitis.1 passage
• Acute-on-chronic liver failure: update on pathogenesis, therapeutic targets, predictive models, and liver transplantation.1 passage
• Advances in chronic intestinal failure management and therapies.1 passage
• Advances in cirrhotic cardiomyopathy.1 passage
• Advances in management of nonvariceal upper gastrointestinal bleeding.1 passage
• Advances in the endoscopic evaluation of eosinophilic esophagitis.1 passage
• Advances in the endoscopic management of gastric outflow disorders.1 passage
• Advances in the treatment of biliary tract cancers.1 passage
• Advances in the treatment of gastric cancer.3 passages
• Advances in the treatment of gastric cancer: 2019.1 passage
• Advances in the treatment of gastric cancer: 2020-2021.1 passage
• Advancing flexible endoscopy to natural orifice transluminal endoscopic surgery.1 passage
• Adverse effects of proton pump inhibitors: fact or fake news?1 passage
• Aging and liver disease.1 passage
• Alcohol and gastrointestinal cancers.1 passage
• Alcoholic hepatitis: current trends in management.1 passage
• An update in the endoscopic management of gastric cancer.1 passage
• An update in the nonendoscopic treatment of gastric cancer.1 passage
• An update on small bowel endoscopy.1 passage
• An update on the pathogenesis of cholesterol gallstone disease.1 passage
• An update on travelers' diarrhea.1 passage
• Anal fissure management by the gastroenterologist.1 passage
• Anti-trafficking agents in the treatment of inflammatory bowel disease.1 passage
• Appendiceal neuroendrocrine neoplasms: incidentaloma or something we should worry about?1 passage
• Approach to the patient with infectious colitis: clinical features, work-up and treatment.1 passage
• Approaches to diet therapy for eosinophilic esophagitis.1 passage
• Autoimmune hepatitis: from immunopathogenesis to diagnostic and therapeutic innovation.1 passage
• Autoimmune pancreatitis type 2.1 passage
• Autophagy and checkpoints for intracellular pathogen defense.1 passage
• Bad blood: ischemic conditions of the large bowel.1 passage
• Bariatric and metabolic surgery: current trends and what's to follow.1 passage
• Bariatric endoscopy: state-of-the-art.1 passage
• Bariatric surgery in managing diabetes mellitus.1 passage
• Best techniques for endoscopic ampullectomy.1 passage
• Beyond pregnancy, women's health in inflammatory bowel disease.1 passage
• Bile acid disease: the emerging epidemic.1 passage
• Bile acids as metabolic regulators.1 passage
• Biomarkers for disease progression of primary sclerosing cholangitis.1 passage
• Biosimilars in inflammatory bowel disease: ready for prime time?1 passage
• Bone loss in patients with inflammatory bowel disease: cause, detection and treatment.1 passage
• Bowel preparation for colonoscopy: what is best and necessary for quality?1 passage
• Breastfeeding and the developmental origins of mucosal immunity: how human milk shapes the innate and adaptive mucosal immune systems.1 passage
• Breath testing for the diagnosis of pancreatic disease.1 passage
• Can SARS-CoV-2 be transmitted via faeces?1 passage
• Can prediction scores be used to identify patients at risk of Clostridioides difficile infection?1 passage
• Cancer cachexia: a multifactoral disease that needs a multimodal approach.1 passage
• Cancer surveillance in ulcerative colitis and Crohn's disease: new strategies.1 passage
• Cancer-associated fibroblasts in cholangiocarcinoma.1 passage
• Carbapenemase-producing Enterobacteriaceae - once positive always positive?1 passage
• Cause and management of muscle wasting in chronic liver disease.1 passage
• Celiac disease: clinical update.1 passage
• Cell therapy in chronic liver disease.1 passage
• Checkpoint inhibitor colitis: a new model of inflammatory bowel disease?1 passage
• Cholangiocarcinoma in patients with primary sclerosing cholangitis.1 passage
• Cholangiocytes derived from induced pluripotent stem cells for disease modeling.1 passage
• Chronic diarrhoea in adults: what not to miss.1 passage
• Chronic infections of the small intestine.1 passage
• Chronic pancreatitis.1 passage
• Chronic pancreatitis: an update on genetic risk factors.1 passage
• Chronic unexplained diarrhea: a logical and cost-effective approach to assessment.1 passage
• Clinical nutrition for the gastroenterologist: bedside strategies for feeding the hospitalized patient.1 passage
• Clinical nutrition for the gastroenterologist: the physiologic rationale for providing early nutritional therapy to the hospitalized patient.1 passage
• Coagulation testing and management in liver disease patients.1 passage
• Colonic and anorectal motility testing in the high-resolution era.1 passage
• Colonic ischemia: usual and unusual presentations and their management.1 passage
• Colour me blue: chromoendoscopy and advanced detection methods in ulcerative colitis.1 passage
• Comparison of the 2010 and 2017 Infectious Diseases Society of America guidelines on the diagnosis and treatment of Clostridium difficile infection.1 passage
• Complications of biologics in inflammatory bowel disease.1 passage
• Complications of chronic pancreatitis in children.1 passage
• Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer: achievements and future directions.1 passage
• Constipation: pathophysiology and management.1 passage
• Contemporary celiac disease diagnosis: is a biopsy avoidable?1 passage
• Control of norovirus infection.1 passage
• Controversies in anticoagulation therapy in patients with cirrhosis.1 passage
• Controversies in criteria for liver transplantation in hepatocellular carcinoma.1 passage
• Coronavirus disease-2019: implications for the gastroenterologist.1 passage
• Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease.1 passage
• Cryoablation in the management of Barrett's esophagus.1 passage
• Current and future pharmacologic treatment of nonalcoholic steatohepatitis.1 passage
• Current concepts in ischemic hepatitis.1 passage
• Current management of acute liver failure.1 passage
• Current role of endoscopic cholangioscopy.1 passage
• Current role of endoscopic pancreatoscopy.1 passage
• Current treatment options for nonalcoholic fatty liver disease.1 passage
• Cytokines and intestinal inflammation.1 passage
• Demographics and risk factors for pediatric recurrent acute pancreatitis.1 passage
• Demystifying autoimmune small bowel enteropathy.1 passage
• Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.1 passage
• Diabetes and pancreatic cancer: recent insights with implications for early diagnosis, treatment and prevention.1 passage
• Diabetes associated with pancreatic diseases.1 passage
• Diabetes in chronic pancreatitis: risk factors and natural history.1 passage
• Diagnosis and evaluation of hyperbilirubinemia.1 passage
• Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease.1 passage
• Diagnosis and treatment of autoimmune pancreatitis.1 passage
• Diagnosis and treatment of dermatologic diseases in inflammatory bowel disease.1 passage
• Diagnosis and treatment of pancreatic exocrine insufficiency.1 passage
• Diagnosis: gastric intestinal metaplasia - what to do next?1 passage
• Diagnostic modalities for the evaluation of small bowel disorders.1 passage
• Diet and cancer of the esophagus and stomach.1 passage
• Diet and colon: what matters?1 passage
• Diet and gastroesophageal reflux disease: role in pathogenesis and management.1 passage
• Diet and irritable bowel syndrome.1 passage
• Dietary interventions and irritable bowel syndrome - what really works?1 passage
• Direct acting antiviral therapy after liver transplantation.1 passage
• Direct-acting antiviral treatment for patients with hepatocellular carcinoma.1 passage
• Distal esophageal spasm.1 passage
• Distinct management issues with Crohn's disease of the small intestine.1 passage
• Distinguishing diabetes secondary to pancreatic diseases from type 2 diabetes mellitus.1 passage
• Diverticular disease: evolving concepts in classification, presentation, and management.1 passage
• Does everyone with inflammatory bowel disease need to be treated with combination therapy?1 passage
• Duodenal chemosensing.1 passage
• Duodenal chemosensory system: enterocytes, enteroendocrine cells, and tuft cells.1 passage
• Early detection of pancreatic cancer.1 passage
• Early detection of pancreatic cancer: current state and future opportunities.1 passage
• Effects of bariatric surgery on the esophagus.1 passage
• Emerging issues in the medical management of Crohn's disease.1 passage
• Emerging pharmacologic therapies for primary sclerosing cholangitis.1 passage
• Endoscope infection transmission state-of-the-art: beyond duodenoscopes to a culture of infection prevention.1 passage
• Endoscopic approaches to gastroesophageal reflux disease.1 passage
• Endoscopic approaches to gastroparesis.1 passage
• Endoscopic diagnosis and management of gastric subepithelial lesions.1 passage
• Endoscopic diagnosis of pancreatic cysts.1 passage
• Endoscopic eradication therapy for Barrett's oesophagus: state of the art.1 passage
• Endoscopic gastroenterostomy: techniques and review.1 passage
• Endoscopic imaging techniques for detecting early colorectal cancer.1 passage
• Endoscopic management of bariatric surgical complications.1 passage
• Endoscopic management of inflammatory bowel disease-associated complications.1 passage
• Endoscopic mucosal resection and endoscopic submucosal dissection: technique and new directions.1 passage
• Endoscopic simulators: training the next generation.1 passage
• Endoscopic techniques for full thickness intestinal biopsy.1 passage
• Endoscopic techniques for myotomy of the lower esophageal sphincter and pylorus.1 passage
• Endoscopic techniques for treating gastroesophageal reflux.1 passage
• Endoscopic techniques for weight loss and treating metabolic syndrome.1 passage
• Endoscopic treatment of obesity.1 passage
• Endoscopic treatment of pain in chronic pancreatitis.1 passage
• Endoscopic ultrasound-guided biliary interventions: an update on recent developments.1 passage
• Endoscopy in the coagulopathic patient.1 passage
• Environmental enteropathy.1 passage
• Eosinophilic colitis and colonic eosinophilia.1 passage
• EsoFLIP for esophageal dilation: proposed advantages.1 passage
• Esophageal afferent innervation and its role in gastro-esophageal reflux disease symptoms.1 passage
• Esophageal dilation in eosinophilic esophagitis: risks, benefits, and when to do it.1 passage
• Esophagitis in patients without gastroesophageal reflux disease or eosinophilic esophagitis: diagnostic considerations.1 passage
• Etiopathogenesis of inflammatory bowel disease: today and tomorrow.1 passage
• Evaluation of abnormal liver tests in the adult asymptomatic patient.1 passage
• Evaluation of the LINX antireflux procedure.1 passage
• Evaluation of very early-onset inflammatory bowel disease.1 passage
• Evidence of cell-fate conversion from hepatocytes to cholangiocytes in the injured liver: in-vivo genetic lineage-tracing approaches.1 passage
• Evolving techniques for endoscopic retrograde cholangiopancreatography in gastric bypass patients.1 passage
• Excluding inflammatory bowel disease in the irritable bowel syndrome patient: how far to go?1 passage
• Exercise, fitness, and the gut.1 passage
• Expanding indications for pancreatic islet cell transplantation.1 passage
• Faecal microbiota replacement to eradicate antimicrobial resistant bacteria in the intestinal tract - a systematic review.1 passage
• Fatigue in inflammatory bowel disease: a problematic ailment.1 passage
• Fecal microbiota transplantation for gastrointestinal disorders.1 passage
• Fecal transplantation: any real hope for inflammatory bowel disease?1 passage
• Fibroblast growth factor receptor 2 fusions as a target for treating cholangiocarcinoma.1 passage
• Fibrosis reversal after hepatitis C virus elimination.1 passage
• Flexible endoscopic strategies for the difficult esophageal stricture.1 passage
• Food allergy: what it is and what it is not?1 passage
• Foodborne transmission of Clostridioides difficile: a review.1 passage
• From bench to bedside: molecular imaging in inflammatory bowel diseases.1 passage
• From coeliac disease to noncoeliac gluten sensitivity; should everyone be gluten free?1 passage
• Functional anatomy and physiology of gastric secretion.1 passage
• Functional dyspepsia and gastroparesis.1 passage
• Functional dyspepsia.2 passages
• Functional lumen imaging probe: The FLIP side of esophageal disease.1 passage
• Gaining resilience and reducing stress in the age of COVID-19.1 passage
• Gallbladder cancer in Chile: what have we learned?1 passage
• Gastric acid secretion.1 passage
• Gastric interventional endoscopy.1 passage
• Gastric intestinal metaplasia: when to treat? How to treat?1 passage
• Gastric variceal bleeding.1 passage
• Gastric vascular abnormalities: diagnosis and management.1 passage
• Gastroduodenal motility disorders.1 passage
• Gastroduodenal mucosal defense mechanisms.1 passage
• Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment.1 passage
• Gastrointestinal bleeding secondary to the new anticoagulants.1 passage
• Gastrointestinal defense mechanisms.1 passage
• Gastrointestinal stromal tumor: epidemiology, diagnosis, and treatment.1 passage
• Gastroparesis and functional dyspepsia: different diseases or different ends of the spectrum?1 passage
• Gastroparesis.2 passages
• Gene-environment interactions in inflammatory bowel disease pathogenesis.1 passage
• Genetic risk in chronic pancreatitis: the misfolding-dependent pathway.1 passage
• Genetically engineered animal models of biliary tract cancers.1 passage
• Genetics in biliary atresia.1 passage
• Genetics of Opisthorchis viverrini-related cholangiocarcinoma.1 passage
• Genetics of gallstone disease revisited: updated inventory of human lithogenic genes.1 passage
• Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants.1 passage
• Genetics of polycystic liver diseases.1 passage
• Global challenges in acute diarrhea.1 passage
• Growth factors and their use in short bowel.1 passage
• Guilt by association: intestinal metaplasia does not progress to gastric cancer.1 passage
• Gut microbiota and sepsis: from pathogenesis to novel treatments.1 passage
• Helicobacter pylori resistance to current therapies.1 passage
• Hemorrhoids: what are the options in 2018?1 passage
• Hepatic manifestations of cystic fibrosis.1 passage
• High-resolution esophageal manometry: interpretation in clinical practice.1 passage
• Host immune interactions in chronic inflammatory gastrointestinal conditions.1 passage
• Host-microbe interactions in the small bowel.1 passage
• How diet can impact gut microbiota to promote or endanger health.1 passage
• How extent of Barrett's metaplasia influences the risk of esophageal adenocarcinoma.1 passage
• How many is too many? Polyposis syndromes and what to do next.1 passage
• How the pathologist can aid in the assessment of gastroesophageal reflux disease.1 passage
• How to advise patients on the risk of chronic proton pump inhibitor therapy.1 passage
• How to choose among fundoplication, magnetic sphincter augmentation or transoral incisionless fundoplication.1 passage
• How to deal with large colorectal polyps: snare, endoscopic mucosal resection, and endoscopic submucosal dissection; resect or refer?1 passage
• How to use Rome IV criteria in the evaluation of esophageal disorders.1 passage
• Human pluripotent stem cell-derived cholangiocytes: current status and future applications.1 passage
• IgG4-related disease of the biliary tract and pancreas: clinical and experimental advances.1 passage
• Ileo-colonic lymphoma: presentation, diagnosis, and management.1 passage
• Imaging for Barrett's esophagus: state of the art.1 passage
• Immune contexture of cholangiocarcinoma.1 passage
• Immune-checkpoint inhibitors induced diarrhea and colitis: a review of incidence, pathogenesis and management.1 passage
• Immunogenetics in primary sclerosing cholangitis.1 passage
• Immunoglobulin G4-related cholangiopathy: clinical and experimental insights.1 passage
• Immunology of pancreatitis and environmental factors.1 passage
• Immunotherapy in cholangiocarcinoma.1 passage
• Impact of bariatric surgery on gastroesophageal reflux disease and esophageal motility.1 passage
• Incidence of gallstone disease and complications.1 passage
• Incorporating image enhanced endoscopy in your everyday practice.1 passage
• Indications of cholecystectomy in gallstone disease.1 passage
• Infectious diseases affecting the small bowel - what not to miss.1 passage
• Inflammation in acute and chronic pancreatitis.1 passage
• Inflammatory bowel disease during pregnancy: management of a disease flare or remission.1 passage
• Inflammatory bowel disease therapy: blockade of cytokines and cytokine signaling pathways.1 passage
• Inflammatory bowel disease treatment in Eastern Europe: current status, challenges and needs.1 passage
• Innate and adaptive immunity in celiac disease.1 passage
• Integration of telemedicine into clinical practice for inflammatory bowel disease.1 passage
• Interventional endoscopic ultrasonography for benign biliary diseases in patients with surgically altered anatomy.1 passage
• Interventional endoscopic ultrasound.1 passage
• Intestinal dendritic cells.1 passage
• Intestinal failure-associated liver disease: causes, manifestations and therapies.1 passage
• Intestinal fibrosis: ready to be reversed.1 passage
• Intestinal microbiota and nonalcoholic steatohepatitis.1 passage
• Intestinal microbiota in primary sclerosing cholangitis.1 passage
• Intestinal transplantation: a review.1 passage
• Intraductal papillary mucinous neoplasms.1 passage
• Intravenous fluid resuscitation in the management of acute pancreatitis.1 passage
• Iron deficiency: a modern primer to diagnosis and management.1 passage
• Iron replacement therapy: do we need new guidelines?1 passage
• Irritable bowel syndrome and colonic diverticular disease: overlapping symptoms and overlapping therapeutic approaches.1 passage
• Irritable bowel syndrome following Clostridium difficile infection.1 passage
• Is there a causal relationship between trehalose consumption and Clostridioides difficile infection?1 passage
• Is there a role of penicillin allergy in developing Clostridioides difficile infection?1 passage
• Is vitamin supplementation appropriate in the healthy old?1 passage
• Leaky gut - concept or clinical entity?1 passage
• Liver disease in patients with cystic fibrosis.1 passage
• Liver transplantation for alcoholic hepatitis: update.1 passage
• Long-term durability of radiofrequency ablation for Barrett's-related neoplasia.1 passage
• Long-term outcomes of treatments for achalasia.1 passage
• Luminal chemosensing in the gastroduodenal mucosa.1 passage
• Macronutrients, microbiome and precision nutrition.1 passage
• Macrophage interactions with fungi and bacteria in inflammatory bowel disease.1 passage
• Magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: pros and cons.1 passage
• Management of Helicobacter pylori.1 passage
• Management of achalasia in 2019.1 passage
• Management of acute pancreatitis in the first 72 hours.1 passage
• Management of choledochal cysts.1 passage
• Management of complications of acute pancreatitis.1 passage
• Management of pancreatic exocrine insufficiency.1 passage
• Management of regurgitation in patients with gastroesophageal reflux disease.1 passage
• Management of small bowel polyps: from small to big.1 passage
• Management of symptom complexes in primary biliary cholangitis.1 passage
• Management of the patient with esophagogastric junction outflow obstruction.1 passage
• Measuring outcomes in complicated intra-abdominal infections.1 passage
• Mechanisms of autoimmune hepatitis.1 passage
• Mesenchymal stem cell therapy for liver disease: current status and future perspectives.1 passage
• Mesenchymal stem/stromal cell therapy for inflammatory bowel disease: an updated review with maintenance of remission.1 passage
• MicroRNAs: how many in inflammatory bowel disease?1 passage
• Modifier genes in cystic fibrosis-related liver disease.1 passage
• Molecular classification of cholangiocarcinoma.1 passage
• Molecular pathogenesis of eosinophilic esophagitis.1 passage
• Molecular targets and the use of biologics in the management of small bowel fibrosis in inflammatory bowel disease.1 passage
• Molecular versus culture-based testing for gastrointestinal infection.1 passage
• Monitoring long-term parenteral nutrition.1 passage
• Mouse models of gallstone disease.1 passage
• Mucosal defense: gastroduodenal injury and repair mechanisms.1 passage
• Mucosal immune responses to fungi and the implications for inflammatory bowel disease.1 passage
• Multidisciplinary management of perianal Crohn's disease.1 passage
• Myths and realities about alcohol and smoking in chronic pancreatitis.1 passage
• NSAIDs and the small bowel.1 passage
• New clinical paradigms for treating and preventing antiplatelet gastrointestinal bleeding.1 passage
• New cross-sectional imaging in IBD.1 passage
• New developments in colorectal surgery.1 passage
• New horizons in pancreatic genetics.1 passage
• New paradigms for organ allocation and distribution in liver transplantation.1 passage
• New systemic agents for hepatocellular carcinoma: an update 2020.1 passage
• New targets in inflammatory bowel disease therapy: 2021.1 passage
• New therapies in Irritable Bowel Syndrome: what works and when.1 passage
• Nonalcoholic fatty liver disease, cholesterol gallstones, and cholecystectomy: new insights on a complex relationship.1 passage
• Nonalcoholic fatty liver disease: new treatments.1 passage
• Noncardiac chest pain: diagnosis and management.1 passage
• Noncirrhotic portal hypertension.1 passage
• Noninvasive assessment of liver function.1 passage
• Noninvasive strategies for colorectal cancer screening: opportunities and limitations.1 passage
• Novel antibiotics in development to treat Clostridium difficile infection.1 passage
• Novel insights into microbiome in colitis and colorectal cancer.1 passage
• Novel treatment options for acute hepatic porphyrias.1 passage
• Novel treatments for alcoholic hepatitis.1 passage
• Nutrient sensing.1 passage
• Nutritional consequences of bariatric surgery - prevention, detection and management.1 passage
• Nutritional consequences of long-term acid suppression; are they clinically important?1 passage
• Nutritional implications of dietary interventions for managing gastrointestinal disorders.1 passage
• Nutritional management of acute pancreatitis.1 passage
• Nutritional regulators of intestinal inflammation.1 passage
• Nutritional therapy in inflammatory bowel disease.1 passage
• Obesity and inflammatory bowel disease: diagnostic and therapeutic implications.1 passage
• Obesity and pancreatitis.1 passage
• Obeticholic acid in primary biliary cholangitis: where we stand.1 passage
• On cell death in the intestinal epithelium and its impact on gut homeostasis.1 passage
• Ondansetron and probiotics in the management of pediatric acute gastroenteritis in developed countries.1 passage
• Opioid-induced esophageal dysfunction.1 passage
• Optimal inflammatory bowel disease management during the global coronavirus disease 2019 pandemic.1 passage
• Optimizing the diagnosis of celiac disease.1 passage
• Paediatric pancreatitis.1 passage
• Painful chronic pancreatitis - new approaches for evaluation and management.1 passage
• Palliative care and end-stage liver disease: a critical review of current knowledge.1 passage
• Pancreatic neuroendocrine tumors.1 passage
• Pancreatic pain.1 passage
• Pancreatic steatosis: an update.1 passage
• Pancreatic stellate cell: physiologic role, role in fibrosis and cancer.1 passage
• Pancreatic stellate cells: what's new?1 passage
• Panorama of mediators in postpancreatitis diabetes mellitus.1 passage
• Pediatric inflammatory bowel disease: continuous lessons for adult inflammatory bowel disease.1 passage
• Per oral endoscopic myotomy for the treatment of achalasia.1 passage
• Peutz-Jeghers syndrome.1 passage
• Pharmacologic management and prevention of acute pancreatitis.1 passage
• Physiologic, pathophysiologic, and pharmacologic regulation of gastric acid secretion.1 passage
• Population-based screening of hepatitis C virus in the United States.1 passage
• Portal hypertensive gastropathy and gastric antral vascular ectasia.1 passage
• Portal vein reconstruction during surgery for cholangiocarcinoma.1 passage
• Positioning biologics and new therapies in the management of inflammatory bowel disease.1 passage
• Positioning biologics and small molecules in the management of moderate to severe ulcerative colitis.1 passage
• Positioning biologics in the management of moderate to severe Crohn's disease.1 passage
• Postoperative Crohn's disease management.1 passage
• Potential of multiomics technology in precision medicine.1 passage
• Pouchitis: diagnosis and management.1 passage
• Practical insights into stomas in inflammatory bowel disease: what every healthcare provider needs to know.1 passage
• Prebiotics and synbiotics: dietary strategies for improving gut health.1 passage
• Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence.1 passage
• Precision medicine for pancreatic diseases.1 passage
• Predictors of clinical outcomes in cirrhosis patients.1 passage
• Primary biliary cholangitis in China.1 passage
• Primary biliary cholangitis: pathogenic mechanisms.1 passage
• Primary biliary cholangitis: treatment.1 passage
• Primary endoscopic therapies for obesity and metabolic diseases.1 passage
• Probiotics for prevention of Clostridium difficile infection.1 passage
• Problems after restorative proctocolectomy: assessment and therapy.1 passage
• Progress with treating the microbial dysbiosis associated with irritable bowel syndrome.1 passage
• Protein-losing enteropathy.1 passage
• Proton pump inhibitor-responsive esophageal eosinophilia: still a valid diagnosis?1 passage
• Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences.1 passage
• Proton pump inhibitors and risk of Clostridium difficile infection: association or causation?1 passage
• Proton pump inhibitors: misconceptions and proper prescribing practice.1 passage
• Proton pump inhibitors: placing putative adverse effects in proper perspective.1 passage
• Quality measures and quality improvements in colonoscopy.1 passage
• Quality measures in gastrointestinal endoscopy: the current state.1 passage
• Radiation enteritis: from diagnosis to management.1 passage
• Radiofrequency ablation for biliary malignancies.1 passage
• Radiofrequency ablation for low-grade dysplasia in Barrett's esophagus.1 passage
• Recent developments in antimicrobial therapy for gastrointestinal infections.1 passage
• Recent developments in colorectal imaging.1 passage
• Recent developments in steroid-responsive pancreatitides (autoimmune pancreatitis).1 passage
• Recent insights into trace element deficiencies: causes, recognition and correction.1 passage
• Reciprocal interaction of diet and microbiome in inflammatory bowel diseases.1 passage
• Reconfiguration of the small intestine and diabetes remitting effects of Roux-en-Y gastric bypass surgery.1 passage
• Refeeding syndrome: update and clinical advice for prevention, diagnosis and treatment.1 passage
• Refractory coeliac disease: what should we be doing different?1 passage
• Renal dysfunction in cirrhosis.1 passage
• Reproducing the human mucosal environment ex vivo: inflammatory bowel disease as a paradigm.1 passage
• Rhythm and bugs: circadian clocks, gut microbiota, and enteric infections.1 passage
• Risk of cancer in inflammatory bowel disease: going up, going down, or still the same?1 passage
• Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis: diagnosis and surveillance.1 passage
• Robotics in flexible endoscopy: current status and future prospects.1 passage
• Role of endoplasmic reticulum stress and autophagy as interlinking pathways in the pathogenesis of inflammatory bowel disease.1 passage
• Role of endoscopic ultrasonography guided fiducial marker placement in gastrointestinal cancer.1 passage
• Role of gut-kidney axis in renal diseases and IgA nephropathy.1 passage
• Role of standardized reporting and novel imaging markers in chronic pancreatitis.1 passage
• Role of the gut-skin axis in IgE-mediated food allergy and atopic diseases.1 passage
• Role of type 2 immunity in intestinal inflammation.1 passage
• Role of visceral fat in colonic inflammation: from Crohn's disease to diverticulitis.1 passage
• Routine disaccharidase testing: are we there yet?1 passage
• Rumination syndrome: when to suspect and how to treat.1 passage
• Runner's diarrhea: what is it, what causes it, and how can it be prevented?1 passage
• Safety considerations with biologics and new inflammatory bowel disease therapies.1 passage
• Sensing of nutrients and microbes in the gut.1 passage
• Seronegative coeliac disease: clearing the diagnostic dilemma.1 passage
• Short-segment and intrasphincteric gastroesophageal reflux.1 passage
• Signatures in drug-induced liver injury.1 passage
• Single-use duodenoscopes: where are we and where are we going?1 passage
• Small bowel bleeding: cause and the role of endoscopy and medical therapy.1 passage
• Small bowel radiology.1 passage
• Small bowel strictures.1 passage
• Small bowel tumours: update in diagnosis and management.1 passage
• Small bowel ulcers: when is it not inflammatory bowel disease ?1 passage
• Small intestinal bacterial overgrowth as a cause for irritable bowel syndrome: guilty or not guilty?1 passage
• Social media in inflammatory bowel disease: the patient and physician perspective.1 passage
• Solitary rectal ulcer syndrome.1 passage
• Sphincter of Oddi dysfunction: sphincter of Oddi dysfunction or discordance? What is the state of the art in 2018?1 passage
• Statins for treatment of chronic liver disease.1 passage
• Stem cell therapy for perianal Crohn's.1 passage
• Stem-cell-derived models: tools for studying role of microbiota in intestinal homeostasis and disease.1 passage
• Strategies that target leukocyte traffic in inflammatory bowel diseases: recent developments.1 passage
• Supragastric belching.1 passage
• Surgical rates in the era of biological therapy: up, down or unchanged?1 passage
• Surgical treatment of pain in chronic pancreatitis.1 passage
• Synthetic human livers for modeling metabolic diseases.1 passage
• Systemic manifestations - do not forget the small bowel.1 passage
• Techniques and principles of endoscopic treatment of benign gastrointestinal strictures.1 passage
• Techniques for endoscopic retrograde cholangiopancreatography in altered gastrointestinal anatomy.1 passage
• The ABC's of re-do ileoanal pouches, what every gastroenterologist should know.1 passage
• The assessment and management of defecatory dysfunction: a critical appraisal.1 passage
• The bi-directional role of the gut-brain axis in inflammatory and other gastrointestinal diseases.1 passage
• The burden of cost in inflammatory bowel disease: a medical economic perspective.1 passage
• The care of the colorectal cancer survivor.1 passage
• The consequences of Campylobacter infection.1 passage
• The cyclical hit model: how paligenosis might establish the mutational landscape in Barrett's esophagus and esophageal adenocarcinoma.1 passage
• The dark side of the colon: current issues surrounding the significance, prevalence, detection, diagnosis and management of serrated polyps.1 passage
• The diminutive colon polyp: biopsy, snare, leave alone?1 passage
• The emerging role of immunotherapy for esophageal cancer.1 passage
• The evolution of antimicrobial resistance in Salmonella Typhi.1 passage
• The evolution of natural history of primary sclerosing cholangitis.1 passage
• The extracellular matrix in IBD: a dynamic mediator of inflammation.1 passage
• The genetic architecture of inflammatory bowel disease: past, present and future.1 passage
• The genetics and molecular biology of colonic neoplasia: practical implications for the clinician.1 passage
• The genetics of primary biliary cholangitis.1 passage
• The globalization of inflammatory bowel disease: the incidence and prevalence of inflammatory bowel disease in Brazil.1 passage
• The gut microbiome as a predictor of low fermentable oligosaccharides disaccharides monosaccharides and polyols diet efficacy in functional bowel disorders.1 passage
• The gut microbiome in health and in disease.1 passage
• The impact of inflammatory bowel disease on women's lives.1 passage
• The importance of anal cancer screening and high-resolution anoscopy to gastroenterology practice.1 passage
• The importance of biopsy sampling practices in the pathologic evaluation of gastrointestinal disorders.1 passage
• The intestinal epithelial cell cycle: uncovering its 'cryptic' nature.1 passage
• The intestinal protozoa: emerging impact on global health and development.1 passage
• The long-term functional consequences of acute infectious diarrhea.1 passage
• The management of the hospitalized ulcerative colitis patient: the medical-surgical conundrum.1 passage
• The mesentery in Crohn's disease: friend or foe?1 passage
• The molecular basis of Clostridium difficile disease and host response.1 passage
• The national institutes of health's approach to address research gaps in pancreatitis, diabetes and early detection of pancreatic cancer.1 passage
• The natural history of alcohol-related liver disease.1 passage
• The overlap of irritable bowel syndrome and noncoeliac gluten sensitivity.1 passage
• The patient with irritable bowel syndrome-type symptoms: when to investigate and how?1 passage
• The potential of microbiome replacement therapies for Clostridium difficile infection.1 passage
• The potential role of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease.1 passage
• The prevention of gastric cancer by Helicobacter pylori eradication.1 passage
• The role of adipose tissue in inflammatory bowel diseases.1 passage
• The role of bariatric surgery in the management of nonalcoholic steatohepatitis.1 passage
• The role of esophageal pH-impedance testing in clinical practice.1 passage
• The role of magnetic sphincter augmentation in the treatment of gastroesophageal reflux disease.1 passage
• The role of small bowel endoscopy for Crohn's disease.1 passage
• The role of the allergist in the management of eosinophilic esophagitis.1 passage
• The role of the transition clinic from pediatric to adult inflammatory bowel disease care.1 passage
• The small bowel microbiota.1 passage
• The treatment approach to inflammatory bowel disease in 2020.1 passage
• The utility of faecal and urine biomarkers for small bowel diseases.1 passage
• The utility of liver biopsy in 2020.1 passage
• Therapeutic drug monitoring in inflammatory bowel disease: for every patient and every drug?1 passage
• Third space endoscopy: the future of treating gastrointestinal dysmotility.1 passage
• Tips for successful deep enteroscopy.1 passage
• To resect or not to resect: a review of pancreatic cyst disease management.1 passage
• Tools for causality assessment in drug-induced liver disease.1 passage
• Total pancreatectomy and islet autotransplantion for chronic and recurrent acute pancreatitis.1 passage
• Total pancreatectomy for recurrent acute and chronic pancreatitis: a critical review of patient selection criteria.1 passage
• Tracking COVID-19 via sewage.1 passage
• Translating nutritional immunology into drug development for inflammatory bowel disease.1 passage
• Transoral incisionless fundoplication: current status.1 passage
• Treatment for eosinophilic esophagitis.1 passage
• Treatment of Helicobacter pylori.1 passage
• Treatment of chronic hepatitis C in patients with cirrhosis.1 passage
• Treatment of walled-off pancreatic necrosis.1 passage
• Treatments for achalasia in 2017: how to choose among them.1 passage
• Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era.1 passage
• Update in Natural Orifice Translumenal Endoscopic Surgery (NOTES).1 passage
• Update in the management of gastric varices.1 passage
• Update on chronic intestinal pseudo-obstruction.1 passage
• Update on innate immunity and perspectives on metabolite regulation in acute pancreatitis.1 passage
• Update on molecular epidemiology of Shigella infection.1 passage
• Update on the management of the liver transplant patient.1 passage
• Updated strategies in the management of acute variceal haemorrhage.1 passage
• Updates in artificial intelligence in gastroenterology endoscopy in 2020.1 passage
• Updates in colorectal cancer screening in inflammatory bowel disease.1 passage
• Updates in the understanding and management of diverticular disease.1 passage
• Updates on hepatitis C virus therapy in the direct-acting antiviral era.1 passage
• Updates on management of nonvariceal upper gastrointestinal bleeding.1 passage
• Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.1 passage
• Utility of esophageal mucosal impedance as a diagnostic test for esophageal disease.1 passage
• Vibration-controlled transient elastography: a practical approach to the noninvasive assessment of liver fibrosis.1 passage
• Vitamin D in inflammatory bowel disease: more than just a supplement.1 passage
• Volumetric laser endomicroscopy in the management of Barrett's esophagus.1 passage
• When is feeding via a percutaneous endoscopic gastrostomy indicated?1 passage
• When is parenteral nutrition indicated in the hospitalized, acutely ill patient?1 passage
• When it is not inflammatory bowel disease: differential diagnosis.1 passage
• Why antibiotics should not be used to treat Shiga toxin-producing Escherichia coli infections.1 passage